Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
This application note presents a novel HTRF cell-based assay that quantifies endogenous phosphorylated retinoblastoma protein.
- Publication Part Number: 5994-3402EN
- Created: 15 Feb 2023
- 589 KB
必威体育登录手机This application note describes the use of the Agilent BioTek Synergy Neo2 hybrid multimode reader to rapidly determine IgG concentrations.
- Publication Part Number: 5994-3387EN
- Created: 11 Feb 2023
- 372 KB
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
- Publication Part Number: 5994-1303EN
- Created: 28 Jan 2023
- 10 MB
This application note introduces a workflow that uses the XF Real-Time ATP rate assay data for identifying metabolic modulator and drug targets.
- Publication Part Number: 5994-5651EN
- Created: 27 Jan 2023
- 2 MB
This application note demonstrates an automated γH2AX assay workflow using a novel cell imaging multimode reader with advanced data analysis capabilities.
- Publication Part Number: 5994-2594EN
- Created: 27 Jan 2023
- 2 MB
必威体育登录手机The Agilent BioTek Gen5 object tracking module combined with Agilent BioTek automated imaging systems delivers an integrated solution for automating cell migration studies, increasing assay robustness and throughput.
- Publication Part Number: 5994-5603EN
- Created: 09 Jan 2023
- 473 KB
必威体育登录手机This application note introduces the Agilent BioTek Gen5 object tracking module, which automates analysis of 2D cell migration in high-content formats, including 96-well microplates.
- Publication Part Number: 5994-5600EN
- Created: 09 Jan 2023
- 243 KB
Hepatocarcinoma is one of the most common cancer types in the U.S.with limited treatment options and poor survival rate.
- Created: 08 Nov 2022
- 1 MB
必威体育登录手机This application note demonstrates the feasibility and use of combining multiple cell-based in vitro assays from Agilent that use diverse analytical technologies to investigate the cardiac liability of drugs.
- Publication Part Number: 5994-5319EN
- Created: 12 Sep 2022
- 1 MB